AI
Wednesday, September 29, 2010 1:37:02 PM
FDA drug approval decision: Arena Pharmaceuticals'(ARNA) lorcaserin for obesity on Oct. 22
FDA drug approval decision: Vivus'(VVUS) Qnexa for obesity on Oct. 28.
FDA drug approval decision: Biodel's(BIOD) Linjeta for diabetes on Oct. 30.
As of now:
ARNA @1.57
VVUS @6.63
BIOD @5.28
ARIA @3.65
PPHM @1.48
more Key Dates for October Biotech Calendar:
http://www.thestreet.com/story/10874282/1/biotech-calendar-key-dates-for-october.html
FDA drug approval decision: Vivus'(VVUS) Qnexa for obesity on Oct. 28.
FDA drug approval decision: Biodel's(BIOD) Linjeta for diabetes on Oct. 30.
As of now:
ARNA @1.57
VVUS @6.63
BIOD @5.28
ARIA @3.65
PPHM @1.48
more Key Dates for October Biotech Calendar:
http://www.thestreet.com/story/10874282/1/biotech-calendar-key-dates-for-october.html
My post is for my own entertainment, do your own DD
before pushing your buy/sell buttons
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
